Sirtex Medical was the big winner on the Australian share market this week while resources stocks were among the biggest fallers.
Shares in the liver cancer treatment group Sirtex Medical soared over 48% this week following an announcement by the Sirtex board on Tuesday that it had agreed to an offer by United States company Varian Medical Systems.
Canstar’s General Manager of Wealth Josh Callaghan said the bid from Varian Medical was for $28 cash per share and represents a bit of a departure from the US company’s usual focus on radiation oncology equipment.
“The bid represents a price of $28 per share for Sirtex whose share price was trading between $13 and $16 through 2017,” he said.
“As expected, their largest shareholder Allan Gray supports the bid.”
James Hardie shares also experienced significant growth, rising 11.8% this week on the back of a positive profit report.
“In the last day of trading for the week, we also saw a strong finish from James Hardie to close at a new 12 month high of $23,” he said.
“This was off the back of the company releasing its third-quarter results which reported a 7% increase in net sales from the prior corresponding nine-month period.”
The industrial building materials company reported a 32.9% rise in third-quarter profit.
“2017 market darling NEXTDC also had another bump this week closing at an all-time high of $6.30,” said Mr Callaghan.
NextDC $NXT remains High Conviction Outperform at RBC Capital, raises price target to $7.50 on re-appraisal market fundamentals #ausbiz #XJO #investing #stocks #equities
— Rudi Filapek-Vandyck (@Filapek) February 1, 2018
Top 5 Winners and Losers of the ASX200 (29/01/2018 to 02/02/2018) | |||||
---|---|---|---|---|---|
Winners | Losers | ||||
Rank | Change (%) | Rank | Change (%) | ||
1 | Sirtex Medical (SRX) | 48.9 | 1 | Pilbara Minerals (PLS) | -9.9 |
2 | James Hardie Industries plc. (JHX) | 11.8 | 2 | Syrah Resources (SYR) | -8.9 |
3 | Nextdc (NXT) | 10.5 | 3 | Credit Corp Group (CCP) | -7.6 |
4 | Vocus Group (VOC) | 9.2 | 4 | Galaxy Resources (GXY) | -7.3 |
5 | Iluka Resources (ILU) | 7.2 | 5 | Viva Energy Reit (VVR) | -5.5 |
Source: Canstar Research, February 2, 2018 Data source: Market Index |
Pilbara Minerals stock prices led the losers table this week with an almost 10% correction in price.
“It all started on Tuesday afternoon for Pilbara Minerals following a corporate presentation which seemed to spark a big sell down immediately afterwards and then a steady continued decline for the rest of the week,” said Mr Callaghan.
Mining company Syrah Resources told investors they will not achieve the sort of prices that had been expected following its initial graphite sales.
“Syrah continued its price decline this week with a fourth consecutive week of declines to remove all of the gains of December and return to the highs of November,” said Mr Callaghan.
“This week’s drop is off the back of the company telling investors they were unable to achieve sale prices as high as the index quoted in the market which has softened revenue expectations of shareholders. ”
Other falls were seen for debt collectors Credit Corp Group and lithium miner Galaxy Resources.
Try our Online Share Trading comparison tool to instantly compare Canstar expert rated options.
This advice is general and has not taken into account your objectives, financial situation, or needs. It is not personal advice. Consider whether this advice is right for you, having regard to your own objectives, financial situation and needs. You may need financial advice from a suitably qualified adviser. For more information, read Canstar’s Financial Services and Credit Guide (FSCG) and our detailed disclosure. Canstar may receive a fee for referring you to a product provider – for further information, see how we get paid. Payment of fees for ads does not influence our Star Ratings or Awards.
Canstar is a comparison website, not a product issuer, so it’s important to check any product information directly with the provider. Consider the Product Disclosure Statement (PDS), Target Market Determination (TMD) and other applicable product documentation before making a decision to purchase, acquire, invest in or apply for a financial or credit product. Contact the product issuer directly for a copy of the PDS, TMD and other documentation.
Canstar is an information provider and in giving you product information Canstar is not making any suggestion or recommendation about a particular credit product or loan. If you decide to apply for a credit product or loan, you will deal directly with a credit provider, and not with Canstar. Rates and product information should be confirmed with the relevant credit provider. For more information, read the credit provider’s key facts sheet and other applicable loan documentation for that product. Read the Comparison Rate Warning.
The views, opinions, and positions expressed in this piece are the views of the author(s) alone, and do not necessarily reflect the views of Canstar.
All information about performance returns is historical. Past performance should not be relied upon as an indicator of future performance; unit prices and the value of your investment may fall or rise.
Canstar is an information provider and in giving you product information Canstar is not making any suggestion or recommendation about a particular product. The information has been prepared without taking into account your individual investment objectives, financial circumstances or needs. Before you decide whether or not to acquire a particular financial product you should assess whether it is appropriate for you in the light of your own personal circumstances, having regard to your own objectives, financial situation and needs. You may wish to obtain financial advice from a suitably qualified adviser before making any decision to acquire a financial product. Please refer to the product disclosure statement (PDS) and Canstar’s Financial Services and Credit Guide (FSCG) for more information, and read our detailed disclosure, important notes and liability disclaimer.
All information about performance returns is historical. Past performance should not be relied upon as an indicator of future performance; unit prices and the value of your investment may fall or rise.
Any advice provided on this website is general and has not taken into account your objectives, financial situation or needs. Consider whether this advice is right for you. Consider the Product Disclosure Statement and Target Market Determination before making a purchase decision. Canstar provides an information service. It is not a credit provider, and in giving you information about credit products Canstar is not making any suggestion or recommendation to you about a particular credit product. Research provided by Canstar Research AFSL and Australian Credit Licence No. 437917. You must not reproduce, transmit, disseminate, sell, or publish information on this website without prior written permission from Canstar.